XOMA Royalty Future Growth
Future criteria checks 5/6
XOMA Royalty is forecast to grow earnings and revenue by 78% and 31.3% per annum respectively while EPS is expected to grow by 78.6% per annum.
Key information
78.0%
Earnings growth rate
78.6%
EPS growth rate
| Biotechs earnings growth | 28.3% |
| Revenue growth rate | 31.3% |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 08 Nov 2024 |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 49 | 3 | N/A | N/A | 3 |
| 12/31/2025 | 36 | -7 | N/A | N/A | 3 |
| 12/31/2024 | 28 | -6 | N/A | N/A | 3 |
| 9/30/2024 | 22 | -35 | -15 | -15 | N/A |
| 6/30/2024 | 15 | -24 | -8 | -8 | N/A |
| 3/31/2024 | 6 | -42 | -13 | -18 | N/A |
| 12/31/2023 | 5 | -46 | -18 | -18 | N/A |
| 9/30/2023 | 4 | -32 | -18 | -18 | N/A |
| 6/30/2023 | 4 | -31 | -20 | -20 | N/A |
| 3/31/2023 | 3 | -30 | -14 | -17 | N/A |
| 12/31/2022 | 6 | -23 | -13 | -13 | N/A |
| 9/30/2022 | 40 | 10 | 42 | 22 | N/A |
| 6/30/2022 | 41 | 10 | 36 | 22 | N/A |
| 3/31/2022 | 41 | 12 | 36 | 23 | N/A |
| 12/31/2021 | 38 | 8 | 23 | 23 | N/A |
| 9/30/2021 | 30 | 1 | -11 | 10 | N/A |
| 6/30/2021 | 29 | 6 | -3 | 10 | N/A |
| 3/31/2021 | 29 | 6 | -2 | 11 | N/A |
| 12/31/2020 | 29 | 9 | 10 | 10 | N/A |
| 9/30/2020 | 2 | -13 | -12 | -12 | N/A |
| 6/30/2020 | 11 | -9 | -18 | -5 | N/A |
| 3/31/2020 | 11 | -10 | -25 | -6 | N/A |
| 12/31/2019 | 18 | -2 | -20 | 0 | N/A |
| 9/30/2019 | 20 | -2 | -18 | 1 | N/A |
| 6/30/2019 | 12 | -8 | -27 | -5 | N/A |
| 3/31/2019 | 13 | -6 | -21 | -6 | N/A |
| 12/31/2018 | 5 | -13 | -28 | -13 | N/A |
| 9/30/2018 | 9 | -11 | -30 | -15 | N/A |
| 6/30/2018 | 44 | 9 | N/A | 18 | N/A |
| 3/31/2018 | 53 | 18 | N/A | 13 | N/A |
| 12/31/2017 | 53 | 6 | N/A | 3 | N/A |
| 9/30/2017 | 48 | -11 | N/A | 15 | N/A |
| 6/30/2017 | 12 | -39 | N/A | -28 | N/A |
| 3/31/2017 | 2 | -61 | N/A | -32 | N/A |
| 12/31/2016 | 6 | -54 | N/A | -34 | N/A |
| 9/30/2016 | 53 | -11 | N/A | -12 | N/A |
| 6/30/2016 | 55 | 1 | N/A | -19 | N/A |
| 3/31/2016 | 57 | -7 | N/A | -23 | N/A |
| 12/31/2015 | 55 | -21 | N/A | -31 | N/A |
| 9/30/2015 | 12 | -53 | N/A | -77 | N/A |
| 6/30/2015 | 15 | -67 | N/A | -74 | N/A |
| 3/31/2015 | 18 | -55 | N/A | -74 | N/A |
| 12/31/2014 | 19 | -38 | N/A | -78 | N/A |
| 9/30/2014 | 27 | -83 | N/A | -68 | N/A |
| 6/30/2014 | 28 | -99 | N/A | -65 | N/A |
| 3/31/2014 | 29 | -104 | N/A | -60 | N/A |
| 12/31/2013 | 35 | -124 | N/A | -46 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: XOMA.O is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.6%).
Earnings vs Market: XOMA.O is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: XOMA.O is expected to become profitable in the next 3 years.
Revenue vs Market: XOMA.O's revenue (31.3% per year) is forecast to grow faster than the US market (8.9% per year).
High Growth Revenue: XOMA.O's revenue (31.3% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if XOMA.O's Return on Equity is forecast to be high in 3 years time